University of Crete (UOC)
Διερεύνηση της δυνατότητας περιστολής της συχνότητας αιματογενών λοιμώξεων που σχετίζονται με τη χρήση μόνιμων φλεβικών καθετήρων σε νεοπλασματικούς ασθενείς: μια προοπτική, τυχαιοποιημένη, διπλά τυφλή μελέτη
Abstract
dc:descriptionPurpose: To evaluate the efficacy of long-term non-tunneled silicone central venous catheters (CVC) impregnated with minocycline and rifampin (MR-CVC) in reducing catheter-related bloodstream infections (CRBSI). Additionally to evaluate the possibility that the clinical use of such catheters is associated with an increased risk for development of staphylococcal resistance to the catheter coating antibiotics. Participants and Methods: Two independent studies were conducted. In order to evaluate the safety and efficacy of MR-CVC in preventing CRBSI, a prospective, randomized, double-blind clinical trial was conducted at M.D. Anderson Cancer Center (MDACC). The participants were randomized to receive either a MR-CVC or an uncoated CVC (control). In order to evaluate the impact of the clinical use of MR-CVC on the susceptibility patterns of bacterial isolates, we conducted a separate retrospective study. Based on the fact that in MDACC all BMT recipients during the pre-engraftment period receive MR-CVC whereas MR-CVCs are not part of standard care in the leukemia department, we evaluated the impact of a 4 year period or MR-CVC clinical use on the susceptibility patterns of Staphylococcus spp. isolates causing primary bloodstream infections in BMT patients. Results: The prospective study took place between September 1999 and May 2002. In total 356 evaluable catheters were used, 182 MR-CVC and 174 non-impregnated ones. A total of 17 catheter-related bloodstream infections occurred, 3 were associated with the use of MR-CVC and 14 with the non-impregnated catheters, with a rate of catheter-related bloodstream infection of 0.25 and 1.28/1,000 catheter-days, respectively (p=0.003). During the study period (July-December 2001) of the retrospective study there were 212 BMT and 460 leukemia in-patients. The rates of primary staphylococcal bacteremia were 1.2 and 5.4/1,000 patient days for BMT and leukemia patients respectively (p=0.003). Nine staphylococcal isolates from the leukemia and one from the BMT service were resistant to rifampin. No resistance to minocycline was recorded. Conclusion: Long-term non-tunneled central venous catheters impregnated with minocycline and rifampin are efficacious and safe in reducing catheter-related bloodstream infections in cancer patients and are associated with low risk of development of staphylococcal resistance to minocycline and rifampin.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzinikolaou, Ioannis
- Χατζηνικολάου, Ιωάννης
Subjects
dc:subject × 18- Βακτηριαιμίες
- Καθετήρας
- Λοιμώξεις
- Πρόληψη
- Μινοκυκλίνη
- Ριφαμπικίνη
- Κεντρικός φλεβικός καθετήρας
- Αντιβιοτική επικάλυψη
- Catheter related infection
- Minocycline
- Rifampin
- Bacteremia
- Prevention
- Central venous catheter
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25082